Active, not recruitingInterventionalPhase 1Last updated Aug 13, 2026

Intrathecal Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells for Children With Cerebral Palsy

Intrathecal Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells in Children With Cerebral Palsy: A Pilot Study of Feasibility, Short-Term Safety, and Exploratory Outcomes

Overview

ClinicalTrials.gov ID: NCT07763028
Lead Sponsor: Gadjah Mada UniversityOTHER
Brief Summary: This is a single-center, open-label, single-arm Phase I pilot study designed to evaluate the feasibility and short-term safety of a single intrathecal administration of allogeneic umbilical cord tissue-derived mesenchymal stromal cells (UCT-MSCs) in children with cerebral palsy (CP).
Study Type

Status

Overall Status: Active, not recruiting
Start Date: Dec 1, 2024Actual
Primary Completion Date: Sep 2026Estimated
Completion Date: Sep 2026Estimated

Study Record Dates

First Submitted: Aug 8, 2026
First Submitted that Met QC Criteria: Aug 8, 2026
First Posted: Aug 13, 2026Actual
Last Update Submitted that Met QC Criteria: Aug 8, 2026
Last Update Posted: Aug 13, 2026Actual
Last Verified: Aug 2026

NCT03473301Completed

A Study of UCB and MSCs in Children With CP: ACCeNT-CP

NCT04314687Active, not recruiting

Stem Cell and Conditioned Medium for Cerebral Palsy

NCT05018819Recruiting

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CP

NCT03795974Unknown status

Efficacy of Allogeneic Umbilical Cord Derived Hematopoietic and Mesenchymal Stem Cells in Cerebral Palsy

NCT06377982Not yet recruiting

Human Umbilical Cord Blood Infusion in Patients with Cerebral Palsy

NCT04873752Completed

A Study to Investigate the Safety and Efficacy of UC-MSCs in Pediatric Patients With Cerebral Palsy